ArticleNeurotoxicity research2026

Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.

Lijian Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.